DEXWireNews

Kintara Therapeutics, Inc. On Breakout Alert

Long
NASDAQ:KTRA   Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

#1 News Source For Stock & Crypto Traders

1) Sign Up for our Free Email Newsletter:
dexwirenews.com/sign-up/

2) Follow Us on Telegram @ t.me/DEXWireNews

3) Subscribe to our YouTube Channel @ youtube.com/@DEXWireNews
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.